Centiva Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
+431
| New | +$226K | ﹤0.01% | 983 |
|
|
2025
Q1 | – | Sell |
-604
| Closed | -$430K | – | 1703 |
|
|
2024
Q4 | $430K | Buy |
+604
| New | +$430K | 0.01% | 653 |
|
|
2024
Q3 | – | Sell |
-66
| Closed | -$69.4K | – | 1920 |
|
|
2024
Q2 | $69.4K | Sell |
66
-421
| -86% | -$442K | ﹤0.01% | 1426 |
|
|
2024
Q1 | $469K | Buy |
487
+460
| +1,704% | +$443K | 0.01% | 734 |
|
|
2023
Q4 | $23.7K | Sell |
27
-1,380
| -98% | -$1.21M | ﹤0.01% | 1164 |
|
|
2023
Q3 | $1.16M | Buy |
+1,407
| New | +$1.16M | 0.03% | 306 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1471 |
|
|
2023
Q1 | – | Sell |
-1,016
| Closed | -$733K | – | 1299 |
|
|
2022
Q4 | $733K | Buy |
1,016
+716
| +239% | +$517K | 0.02% | 378 |
|
|
2022
Q3 | $207K | Sell |
300
-3,271
| -92% | -$2.26M | ﹤0.01% | 728 |
|
|
2022
Q2 | $2.11M | Buy |
3,571
+1,141
| +47% | +$675K | 0.05% | 196 |
|
|
2022
Q1 | $1.7M | Buy |
+2,430
| New | +$1.7M | 0.03% | 265 |
|
|
2021
Q4 | – | Sell |
-749
| Closed | -$454K | – | 1047 |
|
|
2021
Q3 | $454K | Sell |
749
-2,135
| -74% | -$1.29M | 0.03% | 528 |
|
|
2021
Q2 | $1.61M | Buy |
2,884
+452
| +19% | +$252K | 0.04% | 181 |
|
|
2021
Q1 | $1.15M | Buy |
+2,432
| New | +$1.15M | 0.04% | 147 |
|
|
2020
Q1 | – | Sell |
-1,466
| Closed | -$550K | – | 537 |
|
|
2019
Q4 | $550K | Buy |
+1,466
| New | +$550K | 0.03% | 174 |
|
|
2019
Q3 | – | Sell |
-558
| Closed | -$175K | – | 391 |
|
|
2019
Q2 | $175K | Sell |
558
-5,775
| -91% | -$1.81M | 0.01% | 120 |
|
|
2019
Q1 | $2.6M | Buy |
6,333
+3,671
| +138% | +$1.51M | 0.17% | 36 |
|
|
2018
Q4 | $994K | Buy |
+2,662
| New | +$994K | 0.08% | 49 |
|